Searched for
TREATMENT OPTIONS FOR ABS
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....- Vihaan Clean bets on energy solutions and resource recovery to power its next growth phaseEnvironmental infrastructure is emerging as a scalable utility business powered by annuity-led revenue models, shared industrial utilities,...
- Robotic joint replacement surgery and insurance: The gap patients should know aboutRobotic surgery offers better outcomes for knee and hip pain patients. However, many Indians cannot access this advanced treatment due to i...
- Most difficult: Staying invested in businesses while ignoring noise called Gulf war; 19 stocks from different sectors to ‘hold’Businesses that create long-term wealth are those where the demand runway is long, the competitive position is strong, and the management i...
- Union Budget 2026: Has government made any changes to the Ayushman Bharat scheme? Check details hereAll senior citizens aged 70 and above will receive continue to receive health coverage up to Rs 5 lakh annually. This benefit is available ...
- Scientists confirm gut bacteria behind rare auto-brewery syndrome that makes people drunk without drinkingScientists have uncovered the cause of auto-brewery syndrome. Certain gut bacteria, Klebsiella pneumoniae and Escherichia coli, ferment foo...
- Ayushman Bharat PMJAY for senior citizens: Not just benefits but know its limitations to avoid any last-minute shockAyushman Bharat PM-JAY: The central government has expanded the Ayushman Bharat PMJAY scheme to cover all senior citizens aged 70 and above...
- Ayushman Bharat PMJAY for 70+: Senior citizens can’t enrol without this documentAyushman Bharat health insurance: All senior citizens aged 70 or above, regardless of economic status, are eligible for free medical treatm...
- Ayushman Bharat health insurance scheme: States, UTs asked to facilitate enrolment of eligible senior citizensThe Union Health Ministry has urged states and Union Territories to enroll senior citizens aged 70 and above for the Ayushman Bharat health...
- Retain costly health policy or use PMJAY coverage? Seniors have a tough choiceA 70-year-old retiree faces a dilemma over renewing his ₹73,000 health insurance policy or relying on the government's Ayushman Bharat sche...
- Ayushman Bharat health insurance cover for senior citizens above 70 years: Find eligible Ayushman Bharat hospital list near youAyushman Bharat health insurance cover for senior citizens: The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana offers each family health ...
- Media claims about dead people taking treatment under PM-JAY not true: Union Health MinistryThe CAG report which contains results of the Performance Audit on Ayushman Bharat Pradhan Mantri - Jan Arogya Yojana (AB PM-JAY) covering t...
- 'Invalid names, unrealistic DOBs': CAG flags discrepancies in Ayushman Bharat databaseThe CAG report pointed out that several beneficiaries were registered against the same mobile number under the health insurance scheme. It ...
- GSK gears up to bring antibody cocktail drug to India; Zydus ready for trial“We are exploring all options to quickly make this important medicine available for Indian patients,” GSK India spokesperson told ET. Earli...
- Biopharma giant AstraZeneca begins coronavirus dual-use antibody drug trial in UKThe drug known as AZD7442 has the potential to be given as a preventative option for people exposed to the coronavirus, and to treat and pr...
- Uber partners NHA to provide dedicated transport service to COVID-19 healthcare workersUber will initially facilitate the provision of 150 cars free of cost to support medical facilities in New Delhi, Noida, Ghaziabad, Kanpur,...
- Finally, a govt side story to quell India's misgivings about ModicareAyushman Bharat has both supporters who are inspired by the vision and detractors who harbour many doubts.
- Biocon-Mylan's cancer drug gets USFDA nodFulphila is expected to contribute to Biocon’s revenue in FY19, as well as to its profits through a profitshare arrangement with Mylan.
- Lupin launches generic morphine sulfate tablets in USThe company said it has launched the morphine sulfate ER Tablets in strengths of 15 mg, 30 mg, 60 mg, 100 mg and 200 mg having received an ...
- iLife Discoveries brings over 50 genetic tests to IndiaiLife Discoveries is looking at bringing benefits of genetic tests for providing appropriate diagnostics and treatment options for diseases...
Load More
